Join the club for FREE to access the whole archive and other member benefits.

Samsara secures more funding for cellular rejuvenation drug research

Drugs will need to work better than the free alternative - calorie restriction

06-Mar-2019

Key points from article :

Samsara Therapeutics is developing drugs to rejuvenate cells.

Has completed a seed financing round in collaboration with Apollo Ventures,

Currently focusing on autophagy - the cell's natural garbage disposal system .

Using a sophisticated drug screening platform to discover potential geroprotectors.

Samsara recently identified the flavonoid 4,4′-dimethoxychalcone (DMC).

The study was published in Nature Communications.

Mentioned in this article:

Click on resource name for more details.

Apollo Health Ventures

Venture capital firm investing in seed and early stage biotechnology companies

Nature Communications

Journal covering all topics in physics, chemistry, and biology.

Samsara Therapeutics

Company developing therapeutics for life extension.

Topics mentioned on this page:
Investments